Moleculin Biotech“奇迹试验”A部分最终治疗预计2026年9月完成;揭盲结果将于2026年12月至2027年2月公布

美股速递
Jul 31

Moleculin Biotech 的“奇迹试验”A部分迎来关键节点——最终治疗预计在2026年9月落地。紧随其后,揭盲结果将在2026年12月至2027年2月期间揭晓。此次试验的进展,为这家生物科技公司铺就了充满悬念与期待的下一征程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10